Pulmatrix, Inc. (PULM)
NASDAQ: PULM · Real-Time Price · USD
1.270
+0.020 (1.60%)
May 13, 2026, 4:00 PM EDT - Market closed
Pulmatrix Employees
Pulmatrix had 2 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
2
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$2,581,000
Market Cap
4.64M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 2 | 0 | - | 2 | 0 |
| Dec 31, 2024 | 2 | -20 | -90.91% | 2 | 0 |
| Dec 31, 2023 | 22 | -7 | -24.14% | 22 | 0 |
| Dec 31, 2022 | 29 | 4 | 16.00% | 28 | 1 |
| Dec 31, 2021 | 25 | 3 | 13.64% | 24 | 1 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| BiomX | 20 |
| Cardio Diagnostics Holdings | 17 |
| BioRestorative Therapies | 14 |
| Reviva Pharmaceuticals Holdings | 14 |
| Dermata Therapeutics | 9 |
| Enveric Biosciences | 6 |
| Alzamend Neuro | 6 |
| CNS Pharmaceuticals | 5 |
PULM News
- 22 days ago - Pulmatrix Announces Closing of Preferred Stock Transaction as Part of Planned Merger - PRNewsWire
- 6 weeks ago - Pulmatrix to merge with Eos Senolytix - TheFly
- 6 weeks ago - Pulmatrix and Eos SENOLYTIX Announce Merger Agreement to Advance Novel Mitochondrial Therapies to Improve Healthspan - PRNewsWire
- 2 months ago - Pulmatrix announces Cullgen terminates merger agreement - TheFly
- 2 months ago - Pulmatrix Announces Termination of Prior Planned Merger and Continues Pursuit of Alternative Merger Opportunities - PRNewsWire
- 2 months ago - Pulmatrix Announces Year-End and Fourth Quarter 2025 Financial Results - PRNewsWire
- 5 months ago - Pulmatrix and Cullgen continue to pursue merger - TheFly
- 5 months ago - Pulmatrix and Cullgen Continue to Pursue Merger While Granting Each Other Waivers to Explore Alternatives - PRNewsWire